Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: Summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives

BJU International

Volumn 115, Issue 1, 2015, Pages 14-23

  Bach, Thorsten ^a   Muschter, Rolf ^b   Herrmann, Thomas R W ^c   Knoll, Thomas ^d   Scoffone, Cesare M ^e   Laguna, M Pilar ^f   Skolarikos, Andreas ^g   Rischmann, Pascal ^h   Janetschek, Günter ⁱ   De La Rosette, Jean J M C H ^f   Nagele, Udo ^b   Malavaud, Bernard ^h   Breda, Alberto ^j   Palou, Juan ^j   Bachmann, Alexander ^k   Frede, Thomas ^l   Geavlete, Petrisor ^m   Liatsikos, Evangelos ⁿ   Jichlinski, Patrice ^o   Schwaibold, Hartwig E ^p   Chlosta, Piotr ^q   Martov, Alexey G ^r   Lapini, Alberto ^s   Schmidbauer, Joerg ^t   Djavan, Bob ^t   Stenzl, Arnulf ^u   Brausi, Mauricio ^v   Rassweiler, Jens J ^w   more..

^a Asklepios Klinik Harburg   (Germany)

^b Diakoniekrankenhaus Rotenburg ^*  (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Sindelfingen Böblingen Medical Center   (Germany)

^e Department of Orthopaedic Surgery   (Italy)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g SISMANOGLIO HOSPITAL   (Greece)

^h CHU RANGUEIL   (France)

ⁱ PARACELSUS MEDICAL UNIVERSITY   (Austria)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k UNIVERSITY HOSPITAL BASEL   (Switzerland)

^l Helios Klinikum Mullheim   (Germany)

^m Saint John Emergency Clinical Hospital   (Romania)

ⁿ UNIVERSITY OF PATRAS   (Greece)

^o LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^p Kreiskliniken Reutlingen   (Germany)

^q Center of Oncology   (Poland)

^r Department of EndoUrology   (Russian Federation)

^s UNIVERSITY OF FLORENCE   (Italy)

^t MEDICAL UNIVERSITY OF VIENNA   (Austria)

^u UNIVERSITY OF TÜBINGEN   (Germany)

^v Nuovo Ospedale S Agostino   (Italy)

^w Urology Dept   (Germany)

more..

Author keywords

bladder cancer; en bloc resection; narrow band imaging; optical coherence tomography; photodynamic diagnosis; Storz Professional Image Enhancement system; transurethral resection of the bladder

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER THERAPY; CONSENSUS DEVELOPMENT; CYSTOSCOPY; DRUG INSTILLATION; ENDOSCOPE; FLUORESCENCE IMAGING; HIGH DEFINITION ENDOSCOPIC EQUIPMENT; HOLMIUM LASER; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGING SYSTEM; MAGNIFYING ENDOSCOPY; MAINTENANCE THERAPY; NARROW BAND IMAGING; NON MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA; OPTICAL COHERENCE TOMOGRAPHY; PEROPERATIVE COMPLICATION; PHOTODYNAMIC DIAGNOSIS CYSTOSCOPY; PHOTODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TUMOR VOLUME; WHITE LIGHT CYSTOSCOPY; CARCINOMA, TRANSITIONAL CELL; DIAGNOSTIC IMAGING; EUROPE; UROLOGIC NEOPLASMS; UROLOGIC SURGERY;

CARCINOMA, TRANSITIONAL CELL; DIAGNOSTIC IMAGING; EUROPE; HUMANS; UROLOGIC NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 84925229086     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12664     Document Type: Article

References (55)

1. Ferlay JSH, Bray F, Forman D, et al. GLOBOCAN. V1.2,Cancer Incidence and Mortality Worldwide: IARC Cancer Bas No 10 2010. Lyon: International Agency for Research on Cancer, 2008
2. Vrooman OPJ, Witjes JA,. Urinary markers in bladder cancer. Eur Urol 2008; 53: 909-916
3. Van de Aa MN, Steyerberg EW, Bangma C, et al. Cystoscopy revisited as the golden standard for detecting bladder cancer recurrence: diagnsotic review bias in the randomized, prospective CEFUB trial. J Urol 2010; 183: 76-80
4. Carmack AJ, Soloway MS,. The diagnosis and staging of bladder cancer: from RBCs to TURs. Urology 2006; 67: 3-10
5. Aaronson DS, Walsh TJ, Smith JF, et al. Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain releif? BJU Int 2009; 104: 506-509
6. Okhunov Z, Hruby GW, Mirabile G, et al. Prospective comparision of flexible fiberoptic and digital cystoscopes. Urology 2009; 74: 427-430
7. Hermann GG, Mogensen K, Toft BG, Glenthoj A, Pedersen HM,. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided cystoscopy and bladder biopsies. Scand J Urol Nephrol 2012; 46: 31-36
8. Kausch I, Sommerauer M, Montorsi F, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010; 57: 595-606
9. Mowatt G, N'Dow J, Vale L, et al.; Aberdeen Technology Assessment Review (TAR) Group. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 2011; 27: 3-10
10. Burger M, Grossmann HB, Droller M, et al. Photodynamic Diagnosis of non-muscle invasive bladder cancer with hexaaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol 2013; 64: 846-854
11. Karaolides T, Skolarikos A, Bourdoumis A, et al. Hexaminolevulinate-induced fluorescence versus white light during transurehtral resection of noninvasive bladder tumor: does it reduce recurrences? Urology 2012; 80: 354-359
12. Shen P, Yang J, Wuran W, et al. Effects of fluorescent light-guided transurehtral resection on non-muscle-invasive bladder cancer: a Systematic review and meta-analysis. BJU Int 2012; 110: 209-215
13. Draga RO, Grimbergen MC, Kok ET, Jonges TN, van Swol CF, Bosch JL,. Photodynamic diagnosis (5-aminolaevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy. Eur Urol 2010; 57: 655-660
14. Grossman HB, Stenzl A, Fradet Y, et al. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol 2012; 188: 58-62
15. Herr HW, Donat SM,. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008; 102: 1111-1114
16. Cauberg EC, Kloen S, Visser M, et al. de Reijke. Narrow band imaging cystoscopy improves the detection of non-muscle invasive bladder cancer. Urology 2010; 76: 658-663
17. Geavlete B, Jecu M, Multescu R, Georgescu D, Geavlete P,. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer-re-TURBT recurrence rates in a prospective, randomized study. Urology 2010; 76: 664-669
18. Stenzl A, Penkoff H, Dajc-Sommerer E, et al. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial. Cancer 2011; 117: 938-947
19. Jocham D, Witjes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005; 174: 862-866
20. Jicjlinski P, Guillou L, Karlsen SJ, et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 2003; 170: 226-229
21. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marber M,. Hexvix PCB301/01 study group. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004; 171: 135-138
22. Rink M, Babjuk M, Catto JWF, et al. Hexyl Aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol 2013; 64: 624-638
23. Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q,. Narrow band imaging diagnosis of bladder cancer: a systematic review and meta-analyis. BJU Int 2012; 110: 680-687
24. Naselli A, Introini C, Bertolotto F, Spina B, Puppo P,. Narrow band imaging for detection residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int 2010; 105: 208-211
25. Herr HW, Donat SM,. Reduced bladder tumour recurrence rate is associated with narrow-band imaging surveillance cystoscopy. BJU Int 2011; 107: 396-398
26. Cauberg ECC, Mamoulakis C, de la Rosette JJMCH, de Reijke TM,. Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 2011; 29: 503-509
27. Naselli A, Introini C, Timossi L, et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle invasive bladder cancer recurrence. Eur Urol 2012; 61: 908-913
28. Naito S, van Rees Vellinga S, de la Rosette JJMCH,. Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession tot he first milestone-enrollment of 600 patients. J Endourol 2013; 27: 1-3
29. Lerner SP, Goh AC, Tresser NJ, Shen SS,. Optical Coherence Tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 2008; 72: 133-137
30. Karl A, Stepp H, Willmann E, et al. Optical coherence tomography for bladder cancer-ready as a surrogate for optical biopsy?-Results of an prospective mono-centre study. Eur J Med Res 2010; 15: 131-134
31. Hermes B, Spöler F, Naami A, et al. Visualization oft he basement mambrane zone oft he bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Urology 2008; 72: 677-681
32. Schmidbauer J, Remzi M, Klatte T, et al. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma oft he bladder. Eur Urol 2009; 56: 914-919
33. ® fluorescence cystoscopy. J Biomed Opt 2010; 15: 51606-1
34. Bajuk M, Burger M, Zigeuner R, et al. The EAU Guidelines in non-muscle-invasive bladder cancer (TaT1 and CIS)-Text Update March 2013 Uroweb 2013 Available at: http://www.uroweb.org/gls/pdf/05-TaT1-Bladder-Cancer-LR.pdf. Accessed February 2014
35. Brausi M, Collette L, Kurth K, et al. EORTC genito-urinary tract cancer collaborative group. Eur Urol 2002; 41: 523-531
36. Mariappan P, Zachou A, Grigor KM, Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operative experience. Eur Urol 2010; 57: 843-849
37. Brauers A, Buettner R, Jakse G,. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 2001; 165: 808-810
38. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F,. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease specific survival: a prospective randomised clinical trial. Eur Urol 2010; 58: 185-190
39. Gaya JM, Palou J, Cosentino M, Patino D, Rodriguez-Faba O, Villavicencio H,. A second resection could be not necessary in all high garde non-muscle invasive bladder tumours. Actas Urol Esp 2012; 36: 539-544
40. Ukai R, Kawashita E, Ikeda H,. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol 2000; 163: 878-879
41. Fritsche HM, Otto W, Eder F, et al. Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol 2011; 25: 1599-1603
42. Wolters M, Kramer MW, Becker JU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol 2011; 29: 429-432
43. Nagele U, Kugler M, Nicklas A, et al. Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol 2011; 29: 423-427
44. Xishuang S, Deyong Y, Xiangyu C, et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 2010; 24: 69-73
45. Zhu Y, Jiang X, Zhang J, Chen W, Shi B, Xu Z,. Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 2008; 72: 608-612
46. Gao X, Ren S, Xu C, Sun Y,. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int 2008; 102: 1115-1118
47. Yang Y, Wei ZT, Zhang X, Hong BF, Guo G,. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol 2009; 182: 66-69
48. Ukai R, Hashimoto K, Iwasa T, Nakayama H,. Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor. Int J Urol 2010; 17: 708-714
49. Lodde M, Lusardi L, Palermo S, et al. En bloc transurethral resection of bladder tumors: use and limits. Urology 2003; 62: 1089-1091
50. Naselli A, Introini C, Germinale F, Spina B, Puppo P,. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int 2012; 109: 960-963
51. Saito S,. Transurethral en bloc resection of bladder tumors. J Urol 2001; 166: 2148-2150
52. Zhong C, Guo S, Tang Y, Xia S,. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol [Comparative Study]. 2010 28: 157-161
53. Yates DR, Roupret M,. Failure of bacille Calmette-Guerin in patients with high risk non-muscle invasive bladder cancer unsuitable for radical cystectomy: an update of availabe treatment options. BJU Int 2010; 106: 162-167
54. van der Heijden AG, Hulsbergen-Van de Kaa CA, Witjes JA,. The influence of thermo-chemotherapy on bladder tumours: an immunohistological analysis. World J Urol 2007; 25: 303-308
55. Brausi M, Witjes JA, Lamm D, et al. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the international bladder cancer group. J Urol 2011; 186: 2158-2167